Yves Collette

6.4k total citations
90 papers, 3.6k citations indexed

About

Yves Collette is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Yves Collette has authored 90 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 41 papers in Immunology and 20 papers in Virology. Recurrent topics in Yves Collette's work include HIV Research and Treatment (20 papers), Immune Cell Function and Interaction (20 papers) and T-cell and B-cell Immunology (18 papers). Yves Collette is often cited by papers focused on HIV Research and Treatment (20 papers), Immune Cell Function and Interaction (20 papers) and T-cell and B-cell Immunology (18 papers). Yves Collette collaborates with scholars based in France, United States and Belgium. Yves Collette's co-authors include Daniel Olive, Rémy Castellano, Jacques A. Nunès, Hélène Dutartre, Norbert Vey, Audrey Restouin, Pierre Pontarotti, Thomas Prébet, Laurent Pouyet and Wen‐Chin Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Yves Collette

89 papers receiving 3.6k citations

Peers

Countries citing papers authored by Yves Collette

Since Specialization

Citations

This map shows the geographic impact of Yves Collette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Collette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Collette more than expected).

Fields of papers citing papers by Yves Collette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Collette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Collette. The network helps show where Yves Collette may publish in the future.

Co-authorship network of co-authors of Yves Collette

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Collette. A scholar is included among the top collaborators of Yves Collette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Collette. Yves Collette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment 2024 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Sergii Kolodych, (unknown), (unknown), (unknown), (unknown), Rémy Castellano, Emmanuelle Josselin, (unknown), Lina Benajiba, Alexandre Puissant, Oleksandr Koniev, Yves Collette, Coralie Bélanger, Olivier Hermine, Renato C. Monteiro, Pierre Launay	1
2	Venetoclax Resistance in Acute Myeloid Leukemia 2024 ·Cancers ·Sylvain Garciaz, Yves Collette, Norbert Vey	16
3	Downregulation of stromal syntenin sustains AML development 2023 ·EMBO Molecular Medicine ·Raphaël Leblanc, Rania Ghossoub, Armelle Goubard, Rémy Castellano, Joanna Fares, Luc Camoin, Stéphane Audebert, (unknown), (unknown), Cyril Fauriat, Norbert Vey, Sylvain Garciaz, Jean‐Paul Borg, Yves Collette, Michel Aurrand‐Lions, Guido David, Pascale Zimmermann	6
4	In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor 2020 ·Molecular Oncology ·(unknown), (unknown), Marion Le Grand, Laurent Hoffer, S. Betzi, Mikaël Feracci, Philipp O. Tsvetkov, François Devred, Yves Collette, Xavier Morelli, Pedro J. Ballester, Eddy Pasquier	22
5	Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach 2018 ·Journal of Medicinal Chemistry ·Laurent Hoffer, (unknown), (unknown), (unknown), Christophe Müller, Alexey Yu. Fedorov, Carine Derviaux, Agnès Amouric, S. Betzi, Dragos Horvath, Alexandre Varnek, Yves Collette, Sébastien Combes, Philippe Roche, Xavier Morelli	51
6	JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia 2017 ·Cancer Research ·Maria De Grandis, Florence Bardin, Cyril Fauriat, Christophe Zemmour, Abdessamad El-Kaoutari, Arnauld Sergé, Samuel Granjeaud, Laurent Pouyet, Camille Montersino, Anne-Sophie Chrétien, Julien Mozziconacci, Rémy Castellano, Ghislain Bidaut, Jean‐Marie Boher, Yves Collette, Stéphane J.C. Mancini, Norbert Vey, Michel Aurrand‐Lions	18
7	Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer 2016 ·Annals of Oncology ·(unknown), Olivier Cabaud, Emmanuelle Josselin, Pascal Finetti, Ronald K. Castellano, (unknown), (unknown), (unknown), Yves Collette, Patrice Viens, Ana Sofia Gonçalves, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, Daniel Birnbaum, Daniel Olive, François Bertucci, Marc Lopez	103
8	Context-Selective Death of Acute Myeloid Leukemia Cells Triggered by the Novel Hybrid Retinoid-HDAC Inhibitor MC2392 2014 ·Cancer Research ·Floriana De Bellis, Vincenzo Carafa, Mariarosaria Conte, Dante Rotili, (unknown), Filomena Matarese, Kees‐Jan Françoijs, Julien Ablain, Sérgio Valente, (unknown), Armelle Goubard, Yves Collette, (unknown), Joost H.A. Martens, Hugues de Thé, Angela Nebbioso, Antonello Mai, H.G. Stunnenberg, Lucia Altucci	27
9	CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer 2013 ·Cancer Research ·Marine Malleter, Sébastien Tauzin, Alban Bessede, Rémy Castellano, Armelle Goubard, Florence Godey, Jean Lévêque, Pascal Jézéquel, L. Campion, Mario Campone, Thomas Ducret, Gaëtan MacGrogan, Laure Debure, Yves Collette, Pierre Vacher, Patrick Legembre	69
10	The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression 2013 ·Clinical Cancer Research ·(unknown), Julien Wicinski, Olivier Cabaud, Yves Toiron, Pascal Finetti, Emmanuelle Josselin, Hélène Lelièvre, Laurence Kraus‐Berthier, Stéphane Depil, François Bertucci, Yves Collette, Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Christophe Ginestier	113
11	Tumor Selective Cytotoxic Action of a Thiomorpholin Hydroxamate Inhibitor (TMI-1) in Breast Cancer 2012 ·PLoS ONE ·(unknown), Carole Berruyer-Pouyet, Olivier Cabaud, Emmanuelle Josselin, Sébastien Combes, Jean Michel Brunel, Patrice Viens, Yves Collette, Daniel Birnbaum, Marc Lopez	6
12	Alternative Splicing Modulates Autoinhibition and SH3 Accessibility in the Src Kinase Fyn 2009 ·Molecular and Cellular Biology ·(unknown), Maria Paola Paronetto, Sandrine Opi, (unknown), Stéphane Audebert, Vincent Feuillet, Georges Bismuth, Serge Roche, Stefan T. Arold, Claudio Sette, Yves Collette	28
13	Signaling-dependent immobilization of acylated proteins in the inner monolayer of the plasma membrane 2006 ·The Journal of Cell Biology ·(unknown), David Y. Mason, John Marshall, Yves Collette, Sergio Grinstein	29
14	Active Transcription of the Human FASL/CD95L/TNFSF6 Promoter Region in T Lymphocytes Involves Chromatin Remodeling 2006 ·Journal of Biological Chemistry ·Rémy Castellano, Bérengère Vire, Marjorie Pion, Vincent Quivy, Daniel Olive, Ivan Hirsch, Carine Van Lint, Yves Collette	15
15	A Role for the Neuronal Protein Collapsin Response Mediator Protein 2 in T Lymphocyte Polarization and Migration 2005 ·The Journal of Immunology ·Peggy Vincent, Yves Collette, Romain Marignier, Carine Vuaillat, Véronique Rogemond, Nathalie Davoust, Christophe Malcus, Sylvie Cavagna, Antoine Gessain, Irma Machuca‐Gayet, Marie‐Françoise Belin, Tam Quach, Pascale Giraudon	59
16	Coxiella burnetii Avoids Macrophage Phagocytosis by Interfering with Spatial Distribution of Complement Receptor 3 2003 ·The Journal of Immunology ·Christian Capo, (unknown), Yves Collette, Daniel Olive, Eric J. Brown, Didier Raoult, Jean‐Louis Mège	33
17	Potentiation of Tumor Necrosis Factor-Induced NF-κB Activation by Deacetylase Inhibitors Is Associated with a Delayed Cytoplasmic Reappearance of IκBα 2003 ·Molecular and Cellular Biology ·Emmanuelle Adam, Vincent Quivy, Françoise Bex, Alain Chariot, Yves Collette, Caroline Vanhulle, Sonia Schoonbroodt, Véronique Goffin, Thi Lien-Anh Nguyên, Geoffrey Gloire, Géraldine Carrard, Bertrand Friguet, Yvan de Launoit, Arsène Burny, Vincent Bours, Jacques Piette, Carine Van Lint	81
18	Tec Kinases 2000 ·Immunity ·Wen‐Chin Yang, Yves Collette, Jacques A. Nunès, Daniel Olive	117
19	Full Peptide Synthesis, Purification, and Characterization of Six Tat Variants 1999 ·Journal of Biological Chemistry ·Jean‐Marie Péloponèse, Yves Collette, Catherine Grégoire, Christian Bailly, (unknown), Éliane Meurs, Daniel Olive, Erwann Loret	57
20	Non-receptor protein tyrosine kinases as immune targets of viruses 1997 ·Immunology Today ·Yves Collette, Daniel Olive	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact